(Q35162399)

6 August 2017

1 reference

title

High-throughput crystallography to enhance drug discovery (English)

1 reference

6 August 2017

1 reference

1 reference

Andrew Sharff

1

1 reference

6 August 2017

Harren Jhoti

series ordinal

2

1 reference

6 August 2017

publication date

1 June 2003

1 reference

Current Opinion in Chemical Biology

6 August 2017

published in

1 reference

6 August 2017

volume

7

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

340-345

1 reference

Structure-based screening of low-affinity compounds

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

High-throughput structural proteomics using x-rays

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Application of the three-dimensional structures of protein target molecules in structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

An overview of structural genomics.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Structural genomics in North America.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Structural genomics in Europe: slow start, strong finish?

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

1 reference

7 January 2021

Structural genomics: beyond the human genome project

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

High-throughput three-dimensional protein structure determination.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

High-throughput crystallography for lead discovery in drug design.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

The Sequence of the Human Genome

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Science, art and drug discovery: a personal perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Structural genomics programs at the US National Institute of General Medical Sciences

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Structural genomics in the biotechnology sector

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Design of high-throughput methods of protein production for structural biology

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

High-throughput proteomics: protein expression and purification in the postgenomic world.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Structural genomics. Tapping DNA for structures produces a trickle

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

High-throughput x-ray crystallography for structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

The genesis of high-throughput structure-based drug discovery using protein crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

High-throughput protein crystallization

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Microdispensing technologies in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

A robust and scalable microfluidic metering method that allows protein crystal growth by free interface diffusion

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Automated crystal mounting and data collection for protein crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Discovering novel ligands for macromolecules using X-ray crystallographic screening

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900062-0

7 January 2021

10.1016/S1367-5931(03)00062-0

Identifiers

DOI

1 reference

6 August 2017

1 reference